Serum lipocalin-2 levels positively correlate with coronary artery disease and metabolic syndrome
Open Access
- 21 December 2013
- journal article
- Published by Springer Nature in Cardiovascular Diabetology
- Vol. 12 (1) , 176
Abstract
The lipocalin-2 (LCN2) cytokine, primarily known as a protein of the granules of human neutrophils, has been recently reported to be implicated in metabolic and inflammatory disorders. This study was designed to evaluate the relationship between serum LCN2 levels and coronary artery disease (CAD).Keywords
This publication has 37 references indexed in Scilit:
- Lipocalin-2, glucose metabolism and chronic low-grade systemic inflammation in Chinese peopleCardiovascular Diabetology, 2012
- Adipocytokine levels mark endothelial function in normotensive individualsCardiovascular Diabetology, 2012
- The Metabolic Syndrome, Oxidative Stress, Environment, and Cardiovascular Disease: The Great ExplorationExperimental Diabetes Research, 2012
- Association of Neutrophil Gelatinase-Associated Lipocalin With the Severity of Coronary Artery DiseaseThe American Journal of Cardiology, 2009
- C-Reactive Protein Stimulates Myeloperoxidase Release from Polymorphonuclear Cells and Monocytes: Implications for Acute Coronary SyndromesClinical Chemistry, 2009
- Implication of lipocalin-2 and visfatin levels in patients with coronary heart diseaseEuropean Journal of Endocrinology, 2008
- Lipocalin-2 Is an Inflammatory Marker Closely Associated with Obesity, Insulin Resistance, and Hyperglycemia in HumansClinical Chemistry, 2007
- Circulating levels of proinflammatory cytokines and neutrophil-platelet aggregates in patients with coronary artery diseaseThe American Journal of Cardiology, 2005
- Interaction of Oxidative Stress and Inflammatory Response in Coronary Plaque InstabilityArteriosclerosis, Thrombosis, and Vascular Biology, 2003
- Intermediate-density lipoprotein and cholesterol-rich very low density lipoprotein in angiographically determined coronary artery disease.Circulation, 1981